Mitsubishi UFJ Asset Management
CERE

Mitsubishi UFJ Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-211
Closed -$8.63K – 1603
2024
Q2 		$8.63K Hold
211
– – ﹤0.01% 1241
2024
Q1 		$8.92K Hold
211
– – ﹤0.01% 1184
2023
Q4 		$8.88K Hold
211
– – ﹤0.01% 1154
2023
Q3 		$4.61K Buy
+211
New +$5.28K ﹤0.01% 1280

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Mitsubishi UFJ Asset Management's CERE Position: Q3 2024 in Review

Mitsubishi UFJ Asset Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 211 shares — an estimated $8.63K sold.

Mitsubishi UFJ Asset Management first reported a position in CERE in Q3 2023 and held it in 4 quarters. The position peaked at $8.92K in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Mitsubishi UFJ Asset Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 211 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $8.63K.
  • Mitsubishi UFJ Asset Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
  • Mitsubishi UFJ Asset Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $8.92K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q3 2024, filed 8 Nov 2024.